ClinicalTrials.Veeva

Menu

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

A

Althaia Xarxa Assistencial Universitària de Manresa

Status

Enrolling

Conditions

Thyroid Associated Ophthalmopathy
Surgical Procedure, Unspecified

Treatments

Procedure: Standard surgery
Device: 3D printing model/guide.

Study type

Interventional

Funder types

Other

Identifiers

NCT04662190
CEI 20-16

Details and patient eligibility

About

This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy and safety of 3D printing for the planification and simulation of orbital decompression surgery for thyroid-associated orbitopathy.

Enrollment

12 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital decompression (moderate-severe in EUGOGO classification).
  • Volunteers older than 18 years old.
  • Ability to read.
  • Acceptation to participate and signature of informed consent.

Exclusion criteria

  • Younger than 18 years old.
  • Previous orbital surgery.
  • Any coexisting disease preventing follow-up.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

12 participants in 2 patient groups

Control grup
Active Comparator group
Description:
Conventional surgery.
Treatment:
Procedure: Standard surgery
Intervention group
Experimental group
Description:
Surgery planned, simulated and guided by 3D printing.
Treatment:
Device: 3D printing model/guide.

Trial contacts and locations

1

Loading...

Central trial contact

Anna Arnau, PhD; Eduard Pedemonte-Sarrias, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems